Evaluation of the Efficacy of TECAR Therapy on Clinical Symptoms and Electrophysiological Parameters in Patients with Carpal Tunnel Syndrome (CTS)

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20151020024621N11

Enrollment

Registered

2025-05-22

Start date

2025-06-22

Completion date

Unknown

Last updated

2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Carpal Tunnel Syndrome (CTS). Carpal tunnel syndrome

Interventions

Intervention 1: Intervention group: Intervention group: TECAR therapy + wrist splint • TECAR therapy: Definition: TECAR therapy (Transmission of Capacitive and Resistive Energy) is a form of hyperther

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Age: 18–65 years confirmed diagnosis of carpal tunnel syndrome (CTS) mild to moderate CTS pain intensity =4 on the Visual Analog Scale (VAS) experienced CTS symptoms for at least 3 months. Participants must be willing and able to provide informed consent

Exclusion criteria

Exclusion criteria: Prior CTS Surgery Other Upper Limb Disorders Systemic Diseases Pregnancy Concurrent Treatments Severe CTS Contraindications to TECAR Therapy

Design outcomes

Primary

Measure	Time frame
Neurophysiological parameters. Timepoint: before intervention and 2 week after intervention and 3,6 months after intervention. Method of measurement: Checklist&Visual Analogue Scale& Boston Questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactTannaz Ahadi

Iran University of Medical Sciences

tannaz.ahadi@yahoo.com+98 21 8871 8207

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026